May 16, 2019
4D pharma’s Chron’s treating Thetanix meets objective
4D pharma’s study of Thetanix for treating Crohn’s disease has met primary objective, as it showed Thetanix was well tolerated with a good safety profile.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: DDDD